murmuration of birds

thought leadership

Meet Avalere Health at WHIS

September 21, 2026

Turn women’s health innovation into access and impact by connecting with Avalere Health Advisory experts in Boston this October.

A promising innovation can change women’s health only when the evidence, policy environment, value story, and path to adoption align.

Avalere Health Advisory helps organizations navigate these interconnected challenges. We bring together scientific and market evidence, policy and reimbursement expertise, patient and stakeholder perspectives, and commercial strategy to help advance solutions, from unmet need to meaningful real-world impact.

 

Meet our experts at WHIS 2026

Turn women’s health innovation into access and impact.

Schedule a meeting

 

Connecting every dimension of women’s health innovation

Women’s health is shaped by more than clinical innovation alone. Coverage, affordability, fragmented care, underrepresentation in research, and uneven access can determine whether a solution reaches the people it was designed to serve.

With an understanding of these challenges, Avalere Health Advisory helps organizations:

  • Generate evidence that demonstrates clinical, economic, and societal value
  • Navigate evolving policy, coverage, coding, and reimbursement pathways
  • Understand the priorities of patients, providers, payers, and policymakers
  • Identify access barriers and opportunities across diverse populations
  • Translate insight into practical market and commercialization strategies

From reproductive and maternal health to oncology, cognitive health, menopause, diagnostics, and digital health, we help clients see the whole landscape—and make data-driven decisions within it.

Meet the team

Dr. Laura Housman, SVP & Practice Director, Advisory, and Chief Public Health Officer: Laura works at the intersection of evidence, commercialization, market access, and public health, helping organizations translate healthcare innovation into improved outcomes and measurable value.

Monica Pham, Managing Director, Advisory: Monica partners with clients to shape federal and state strategic policy, by translating coverage, reimbursement, patient affordability, market access considerations and SDOH into commercial decision points, shaping the path from innovation to patient access in therapeutic areas such as neurology, maternal health, autoimmune, and rare disease.

Agata Pelka, JD, Principal, Advisory: Agata helps clients translate complex federal and state policy developments—including coverage, benefit design, affordability, and patient-access considerations—into practical business strategies.

 

Start a conversation

Whether you are developing a women’s health portfolio, bringing an innovation to market, strengthening its evidence base, or addressing barriers to coverage and adoption, our team can help you identify the path forward.

Schedule a meeting